Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TEDUGLUTIDE
- A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Who Are 4 Months or Older
- A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants
- Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients
- Pilot Study to Investigate the Effect of Teduglutide on Temporary Ileostomy Function and Complications
- Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins
- Therapeutic Approaches to Malnutrition Enteropathy
- Study of Teduglutide in Japanese Participants With Short Bowel Syndrome
- An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004
- Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome
- Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients
- L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release
- Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids
- Plasma Lipoprotein Response to Glucagon-like Peptide-2
- A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302
- Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support
- Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)
- Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study
- Teduglutide for Enterocutaneous Fistula (ECF)
- Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
- A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV
- Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)
- Short Bowel Syndrome and Teduglutide Versus Placebo
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome
- A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
- Effect of Teduglutide on Gastric Emptying in Healthy Subjects
- Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers
- Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function
- Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)
- A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of Teduglutide
- Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants
- Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects
- Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
- Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
- Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
Clinical trials list
click for details